Edgestream Partners L.P. Has $2.18 Million Holdings in Agilent Technologies, Inc. $A

Edgestream Partners L.P. trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 51.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,436 shares of the medical research company’s stock after selling 19,321 shares during the period. Edgestream Partners L.P.’s holdings in Agilent Technologies were worth $2,176,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in A. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies during the 1st quarter worth about $30,000. Ransom Advisory Ltd acquired a new position in Agilent Technologies during the first quarter worth approximately $32,000. Central Pacific Bank Trust Division bought a new stake in Agilent Technologies in the second quarter valued at approximately $33,000. Zions Bancorporation National Association UT acquired a new position in shares of Agilent Technologies during the 1st quarter worth approximately $38,000. Finally, Ameritas Advisory Services LLC bought a new stake in Agilent Technologies in the 2nd quarter valued at $64,000.

Analyst Ratings Changes

A number of research firms have commented on A. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. Morgan Stanley started coverage on shares of Agilent Technologies in a report on Tuesday. They set an “overweight” rating for the company. Robert W. Baird increased their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. Barclays boosted their price objective on Agilent Technologies from $145.00 to $165.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 25th. Finally, Wall Street Zen raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $161.08.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $148.08 on Friday. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. The company has a market cap of $41.98 billion, a PE ratio of 32.40, a price-to-earnings-growth ratio of 4.33 and a beta of 1.27. The company has a 50 day moving average of $144.40 and a 200-day moving average of $127.69. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last released its earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The firm had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same period in the prior year, the company earned $1.46 earnings per share. The company’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, January 6th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.25. Agilent Technologies’s dividend payout ratio is 21.66%.

Insider Buying and Selling

In related news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president owned 31,846 shares of the company’s stock, valued at $4,935,811.54. This trade represents a 8.61% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total value of $1,873,500.00. Following the completion of the transaction, the chief executive officer directly owned 33,448 shares of the company’s stock, valued at approximately $5,017,200. The trade was a 27.19% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.